These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 24614922

  • 1. Natural killer cell-mediated shedding of ULBP2.
    Wang R, Sun PD.
    PLoS One; 2014; 9(3):e91133. PubMed ID: 24614922
    [Abstract] [Full Text] [Related]

  • 2. The human NKG2D ligand ULBP2 can be expressed at the cell surface with or without a GPI anchor and both forms can activate NK cells.
    Fernández-Messina L, Ashiru O, Agüera-González S, Reyburn HT, Valés-Gómez M.
    J Cell Sci; 2011 Feb 01; 124(Pt 3):321-7. PubMed ID: 21224393
    [Abstract] [Full Text] [Related]

  • 3. Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein.
    Rölle A, Mousavi-Jazi M, Eriksson M, Odeberg J, Söderberg-Nauclér C, Cosman D, Kärre K, Cerboni C.
    J Immunol; 2003 Jul 15; 171(2):902-8. PubMed ID: 12847260
    [Abstract] [Full Text] [Related]

  • 4. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells.
    Matusali G, Tchidjou HK, Pontrelli G, Bernardi S, D'Ettorre G, Vullo V, Buonomini AR, Andreoni M, Santoni A, Cerboni C, Doria M.
    FASEB J; 2013 Jun 15; 27(6):2440-50. PubMed ID: 23395909
    [Abstract] [Full Text] [Related]

  • 5. RAET1E2, a soluble isoform of the UL16-binding protein RAET1E produced by tumor cells, inhibits NKG2D-mediated NK cytotoxicity.
    Cao W, Xi X, Hao Z, Li W, Kong Y, Cui L, Ma C, Ba D, He W.
    J Biol Chem; 2007 Jun 29; 282(26):18922-8. PubMed ID: 17470428
    [Abstract] [Full Text] [Related]

  • 6. Human Natural Killer cell expression of ULBP2 is associated with a mature functional phenotype.
    Brennan K, McSharry BP, Keating S, Petrasca A, O'Reilly VP, Keane J, Doherty DG, Gardiner CM.
    Hum Immunol; 2016 Oct 29; 77(10):876-885. PubMed ID: 27349945
    [Abstract] [Full Text] [Related]

  • 7. Resveratrol sensitized leukemia stem cell-like KG-1a cells to cytokine-induced killer cells-mediated cytolysis through NKG2D ligands and TRAIL receptors.
    Hu L, Cao D, Li Y, He Y, Guo K.
    Cancer Biol Ther; 2012 May 29; 13(7):516-26. PubMed ID: 22406996
    [Abstract] [Full Text] [Related]

  • 8. Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition.
    Raneros AB, Minguela A, Rodriguez RM, Colado E, Bernal T, Anguita E, Mogorron AV, Gil AC, Vidal-Castiñeira JR, Márquez-Kisinousky L, Bulnes PD, Marin AM, Garay MCG, Suarez-Alvarez B, Lopez-Larrea C.
    Oncotarget; 2017 May 09; 8(19):31959-31976. PubMed ID: 28404876
    [Abstract] [Full Text] [Related]

  • 9. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.
    Schwinn N, Vokhminova D, Sucker A, Textor S, Striegel S, Moll I, Nausch N, Tuettenberg J, Steinle A, Cerwenka A, Schadendorf D, Paschen A.
    Int J Cancer; 2009 Apr 01; 124(7):1594-604. PubMed ID: 19089914
    [Abstract] [Full Text] [Related]

  • 10. Proteolytic release of soluble UL16-binding protein 2 from tumor cells.
    Waldhauer I, Steinle A.
    Cancer Res; 2006 Mar 01; 66(5):2520-6. PubMed ID: 16510567
    [Abstract] [Full Text] [Related]

  • 11. Differential NKG2D binding to highly related human NKG2D ligands ULBP2 and RAET1G is determined by a single amino acid in the alpha2 domain.
    Wittenbrink M, Spreu J, Steinle A.
    Eur J Immunol; 2009 Jun 01; 39(6):1642-51. PubMed ID: 19424970
    [Abstract] [Full Text] [Related]

  • 12. UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells.
    Sutherland CL, Chalupny NJ, Schooley K, VandenBos T, Kubin M, Cosman D.
    J Immunol; 2002 Jan 15; 168(2):671-9. PubMed ID: 11777960
    [Abstract] [Full Text] [Related]

  • 13. Human anaplastic thyroid carcinoma cells are sensitive to NK cell-mediated lysis via ULBP2/5/6 and chemoattract NK cells.
    Wennerberg E, Pfefferle A, Ekblad L, Yoshimoto Y, Kremer V, Kaminskyy VO, Juhlin CC, Höög A, Bodin I, Svjatoha V, Larsson C, Zedenius J, Wennerberg J, Lundqvist A.
    Clin Cancer Res; 2014 Nov 15; 20(22):5733-44. PubMed ID: 25212604
    [Abstract] [Full Text] [Related]

  • 14. TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells.
    Eisele G, Wischhusen J, Mittelbronn M, Meyermann R, Waldhauer I, Steinle A, Weller M, Friese MA.
    Brain; 2006 Sep 15; 129(Pt 9):2416-25. PubMed ID: 16891318
    [Abstract] [Full Text] [Related]

  • 15. The regulatory effect of UL-16 binding protein-3 expression on the cytotoxicity of NK cells in cancer patients.
    Mou X, Zhou Y, Jiang P, Zhou T, Jiang Q, Xu C, Liu H, Zheng T, Yuan G, Zhang Y, Chen D, Mao C.
    Sci Rep; 2014 Aug 20; 4():6138. PubMed ID: 25138242
    [Abstract] [Full Text] [Related]

  • 16. Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2.
    Textor S, Fiegler N, Arnold A, Porgador A, Hofmann TG, Cerwenka A.
    Cancer Res; 2011 Sep 15; 71(18):5998-6009. PubMed ID: 21764762
    [Abstract] [Full Text] [Related]

  • 17. A nanoscale reorganization of the IL-15 receptor is triggered by NKG2D in a ligand-dependent manner.
    Bálint Š, Lopes FB, Davis DM.
    Sci Signal; 2018 Apr 10; 11(525):. PubMed ID: 29636390
    [Abstract] [Full Text] [Related]

  • 18. Cisplatin enhances NK cells immunotherapy efficacy to suppress HCC progression via altering the androgen receptor (AR)-ULBP2 signals.
    Shi L, Lin H, Li G, Sun Y, Shen J, Xu J, Lin C, Yeh S, Cai X, Chang C.
    Cancer Lett; 2016 Apr 01; 373(1):45-56. PubMed ID: 26805759
    [Abstract] [Full Text] [Related]

  • 19. Clinical Impact of Natural Killer Group 2D Receptor Expression and That of Its Ligand in Ovarian Carcinomas: A Retrospective Study.
    Lee GH, An HJ, Kim TH, Kim G, Park KS, Park H, Lee TH, Kwon AY.
    Yonsei Med J; 2021 Apr 01; 62(4):288-297. PubMed ID: 33779082
    [Abstract] [Full Text] [Related]

  • 20. Altered NK-cell compartment and dysfunctional NKG2D/NKG2D-ligand axis in patients with ataxia-telangiectasia.
    Desimio MG, Finocchi A, Di Matteo G, Di Cesare S, Giancotta C, Conti F, Chessa L, Piane M, Montin D, Dellepiane M, Rossi P, Cancrini C, Doria M.
    Clin Immunol; 2021 Sep 01; 230():108802. PubMed ID: 34298181
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.